Developing antibody tests for SARS-CoV-2.
作者信息
Petherick Anna
出版信息
Lancet. 2020 Apr 4;395(10230):1101-1102. doi: 10.1016/S0140-6736(20)30788-1.
Abstract
摘要
相似文献
1
Developing antibody tests for SARS-CoV-2.
Lancet. 2020 Apr 4;395(10230):1101-1102. doi: 10.1016/S0140-6736(20)30788-1.
2
Testing for SARS-CoV-2 antibodies.
BMJ. 2020 Sep 8;370:m3325. doi: 10.1136/bmj.m3325.
3
Clinical Performance of the Roche SARS-CoV-2 Serologic Assay.
Clin Chem. 2020 Aug 1;66(8):1107-1109. doi: 10.1093/clinchem/hvaa132.
4
High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
J Clin Microbiol. 2020 Oct 21;58(11). doi: 10.1128/JCM.01352-20.
5
Interpreting Diagnostic Tests for SARS-CoV-2.
JAMA. 2020 Jun 9;323(22):2249-2251. doi: 10.1001/jama.2020.8259.
6
Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies.
Clin Chem. 2020 Aug 1;66(8):1104-1106. doi: 10.1093/clinchem/hvaa131.
7
Combining Rapid PCR and Antibody Tests Improved COVID-19 Diagnosis.
JAMA. 2020 Oct 13;324(14):1386. doi: 10.1001/jama.2020.19129.
8
Labs scramble to produce new coronavirus diagnostics.
Science. 2020 Feb 14;367(6479):727. doi: 10.1126/science.367.6479.727.
9
Covid-19 antibody tests: a briefing.
BMJ. 2020 Jun 24;369:m2284. doi: 10.1136/bmj.m2284.
10
SARS-CoV-2 Serology: Much Hype, Little Data.
Clin Chem. 2020 Jul 1;66(7):875-877. doi: 10.1093/clinchem/hvaa107.
引用本文的文献
1
Antibodies response in symptomatic and asymptomatic SARS-CoV-2 infected persons in Thailand.
PLoS One. 2025 Feb 11;20(2):e0308850. doi: 10.1371/journal.pone.0308850. eCollection 2025.
2
Comprehensive Study of the IBMP ELISA IgA/IgM/IgG COVID-19 Kit for SARS-CoV-2 Antibody Detection.
Diagnostics (Basel). 2024 Jul 13;14(14):1514. doi: 10.3390/diagnostics14141514.
3
Preamplification-free viral RNA diagnostics with single-nucleotide resolution using MARVE, an origami paper-based colorimetric nucleic acid test.
Nat Protoc. 2024 Nov;19(11):3426-3455. doi: 10.1038/s41596-024-01022-x. Epub 2024 Jul 18.
4
A SARS-CoV-2 minimum data standard to support national serology reporting.
Ann Clin Biochem. 2024 Nov;61(6):418-445. doi: 10.1177/00045632241261274. Epub 2024 Jun 17.
5
Spike 1 trimer, a nanoparticle vaccine against porcine epidemic diarrhea virus induces protective immunity challenge in piglets.
Front Microbiol. 2024 Apr 8;15:1386136. doi: 10.3389/fmicb.2024.1386136. eCollection 2024.
6
Blood Plasma Microfluidic Device: Aiming for the Detection of COVID-19 Antibodies Using an On-Chip ELISA Platform.
Trans Indian Natl Acad Eng. 2020;5(2):217-220. doi: 10.1007/s41403-020-00123-9. Epub 2020 Jun 10.
7
Exploring cell-free assays for COVID-19 serosurvey.
Sci Rep. 2024 Mar 13;14(1):6096. doi: 10.1038/s41598-024-55852-6.
8
Advances and Challenges in SARS-CoV-2 Detection: A Review of Molecular and Serological Technologies.
Diagnostics (Basel). 2024 Feb 29;14(5):519. doi: 10.3390/diagnostics14050519.
9
Fusing Peptide Epitopes for Advanced Multiplex Serological Testing for SARS-CoV-2 Antibody Detection.
ACS Bio Med Chem Au. 2023 Aug 30;4(1):37-52. doi: 10.1021/acsbiomedchemau.3c00010. eCollection 2024 Feb 21.
10
Function and mechanism of bispecific antibodies targeting SARS-CoV-2.
Cell Insight. 2024 Feb 3;3(2):100150. doi: 10.1016/j.cellin.2024.100150. eCollection 2024 Apr.
Zotero 插件